-
521
Air-liquid interface culture alters the characteristics and functions of monolayers generated from human iPS cell‑derived enterocyte‑like cell organoids
Published 2025-06-01“…Thus, there is room for some adjustment in the ALI culture model to optimize its applicability to pharmacokinetic studies using ELC-org-mono.…”
Get full text
Article -
522
Silybin Cocrystals with Improved Solubility and Bioavailability
Published 2025-01-01“…Dissolution tests were conducted in various pH solutions, and the impact of precipitation inhibitors was evaluated. Furthermore, pharmacokinetic study in rats were performed to assess the bioavailability. …”
Get full text
Article -
523
Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
Published 2025-01-01“…This study aimed to identify potential Indonesian phytoconstituents that inhibit PPARG both from a pharmacokinetic and pharmacodynamic perspective based on the in silico approach. …”
Get full text
Article -
524
Determination of Platycodin D and Platycodin D3 in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
Published 2014-01-01“…The present method can be applied to pharmacokinetic analysis of platycodins and platycosides of the PG.…”
Get full text
Article -
525
Magnetic precision: Unleashing the therapeutic potential of paclitaxel-loaded nanoparticles in breast cancer treatment
Published 2024-06-01“…This study employs a comprehensive methodology encompassing various in vitro characterizations, cytotoxicity assessments, cellular uptake studies, in vivo experiments, and pharmacokinetic analyses to systematically evaluate the efficacy of paclitaxel-loaded MNPs. …”
Get full text
Article -
526
Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill
Published 2022-01-01“…To assess the agreement in 24-hour area under the curve (AUC24) value estimates between commonly used vancomycin population pharmacokinetic models in the critically ill. Materials and Methods. …”
Get full text
Article -
527
Effects of Oral Ginger Supplementation on the INR
Published 2019-01-01“…This brief case report discusses the potential scope of the problem as well as the proposed pharmacokinetic and pharmacodynamic interactions between these two commonly used agents.…”
Get full text
Article -
528
Bioequivalence study of fluticasone propionate nebuliser suspensions in healthy Chinese subjects
Published 2025-01-01“…No severe, suspicious or unexpected serious adverse reactions were reported.ConclusionThe test and reference formulations of fluticasone propionate nebuliser suspension were pharmacokinetic bioequivalent and were well tolerated and safe in all subjects.…”
Get full text
Article -
529
Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity
Published 2025-01-01“…Our maternal-fetal physiologically based pharmacokinetic model can guide future studies to inform risks associated with prenatal cannabis use.…”
Get full text
Article -
530
Risk Factors and Prevention of Upper Gastrointestinal Complications Associated with Nonsteroidal Anti-Inflammatory Drugs
Published 2025-02-01“…Esomeprazole has a number of pharmacokinetic advantages — a large area under the pharmacokinetic curve, the ability to inhibit CYP4502C19, which determines the high efficiency of therapy in fast and ultrafast metabolizers. …”
Get full text
Article -
531
Natural Cyclic Peptides: Synthetic Strategies and Biomedical Applications
Published 2025-01-01“…Their unique ability to combine high specificity with desirable pharmacokinetic properties makes them valuable tools in addressing unmet medical needs, such as combating drug-resistant pathogens and targeting challenging biological pathways. …”
Get full text
Article -
532
Exploring the antifungal potential of Cannabis sativa-derived stilbenoids and cannabinoids against novel targets through in silico protein interaction profiling
Published 2025-01-01“…The ligands with the highest binding affinities were identified, and their pharmacokinetic profiles were analyzed using ADMET analysis. …”
Get full text
Article -
533
Computational analysis of Allium sativum compounds to identify thermolabile hemolysin inhibitors against Vibrio alginolyticus in shrimp
Published 2025-03-01“…Various computational approaches, including molecular docking, pharmacokinetic analysis, and molecular dynamics simulation, were conducted to predict the compounds that can inhibit the phospholipase and hemolysis activities of the thermolabile hemolysin protein. …”
Get full text
Article -
534
Phytosome-Enhanced Secondary Metabolites for Improved Anticancer Efficacy: Mechanisms and Bioavailability Review
Published 2025-01-01“…This review aims to investigate how phytosome encapsulation improves the pharmacokinetic profiles and anticancer effectiveness of these bioactive compounds.Patients and Methods: This comprehensive review is based on an analysis of recent literature retrieved from PubMed, Scopus, and ScienceDirect databases. …”
Get full text
Article -
535
Liposome-like encapsulation of fish oil-based self-nano emulsifying formulation for improved bioavailability
Published 2025-06-01“…The enhanced pharmacokinetic profile suggests that this novel formulation could offer superior clinical benefits, including but not limited to managing lipid profile and hypertension, improving cognition, glycaemic control, and reducing inflammation. …”
Get full text
Article -
536
Investigations of Long-Acting Formulations in Children, Adolescents, and Pregnant Women: A Systematic Review
Published 2025-01-01“…Only 9.3% of the studies in children and 16.7% of the studies in pregnant people collected any pharmacokinetic (PK) data. <b>Conclusions:</b> Long-acting formulations may behave differently (both pharmacokinetically and pharmacodynamically) in childhood, adolescence, and pregnancy as compared to non-pregnant adulthood. …”
Get full text
Article -
537
On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
Published 2013-03-01“…In this paper, we briefly discuss therationale behind this therapy approach and, using as examplemulti-drug cancer chemotherapy with a cytotoxic and cytostatic agent, show thatthese types of protocols are optimal in the sense of minimizing a weightedaverage of the number of tumor cells (taken both at the end of therapy and atintermediate times) and the total dose given if it is assumed that the tumorconsists of a homogeneous population of chemotherapeutically sensitive cells.A $2$-compartment linear model is used to model the pharmacokinetic equations for the drugs.…”
Get full text
Article -
538
Critically Ill Patients with Renal Hyperfiltration: Optimizing Antibiotic Dose
Published 2023-01-01“…The current review discusses the available evidence related to the RHF phenomenon, including definition, epidemiology, risk factors, pathophysiology, pharmacokinetic variability, and considerations for optimizing the dosage of antibiotics in critically ill patients.…”
Get full text
Article -
539
Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
Published 2018-01-01“…This report includes a brief review of the pharmacokinetic properties of everolimus, a review of the relevant literature, and an analysis using the RUCAM and Naranjo algorithms.…”
Get full text
Article -
540
A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
Published 2025-01-01“…Discussion This case highlights the pharmacokinetic interaction between valproate and paliperidone, which can elevate plasma levels of paliperidone and exacerbate EPS. …”
Get full text
Article